JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (8): 71-75.doi: 10.6040/j.issn.1671-7554.0.2016.1195

Previous Articles     Next Articles

Application of computed tomography sagittal reconstruction for microwave ablation of hepatic carcinoma under the diaphragm

WANG Ningning1, QU Linli1, CAO Fangli1,2, LIANG Lei1   

  1. 1. Department of Chemotherapy, Qilu Hospital of Shandong University, Qingdao 266035, Shandong, China;
    2. Department of Oncology, Liaocheng Peoples Hospital, Liaocheng 252000, Shandong, China
  • Received:2016-09-23 Online:2017-08-10 Published:2017-08-10

PDF (PC)

162

Abstract: Objective To evaluate the efficacy of computed tomography(CT)sagittal reconstruction for microwave ablation of hepatic tumor under the diaphragm. Methods A total of 8 patients with primary liver cancer and 2 patients with hepatic metastases(altogether 11 lesions)who underwent microwave ablation with CT sagittal reconstruction were involved. During the follow-up of 36 months, the tumor clearance rate, local recurrence rate, survival rate, distant metastasis and changes of alpha fetal protein(AFP)were observed. Results The overall clearance rate was 90.9%. Of the 3 patients with preoperative AFP ≥ 200 ng/mL, 1 patient had AFP reduced to < 200 ng/mL. The 1-, 2- and 3-year local recurrence rate was 20%, 30% and 30%. The 1-, 2- and 3-year overall survival(OS)was 100%, 60% and 50%. No serious operation-related complications were observed. Conclusion Microwave ablation of hepatic carcinoma under the diaphragm with CT sagittal reconstruction is a preferred method if patients are unresectable.

Key words: Hepatic carcinoma, CT Sagittal reconstruction, Microwave ablation, Under the diaphragm

CLC Number: 

  • R735.7
[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 临床肿瘤学杂志,2011,16(10):929-946.
[3] 谭凯, 杜锡林, 杨涛, 等. 肝癌合并门静脉癌栓术后门静脉化疗疗效分析[J]. 西部医学, 2015, 27(7): 989-995. TAN Kai, DU Xilin, YANG Tao, et al. The efficacy of portal vein chemotherapy on patients with liver cancer complicated with portal vein tumor thrombus undergoing hepatectomy[J]. Med J West China, 2015, 27(7): 989-995.
[4] Weledji EP, Enow Orock G, Ngowe MN, et al. How grim is hepatocellular carcinoma[J]. Ann Med Surg(Lond), 2014, 3(3): 71-76.
[5] 庄兴俊, 王宁宁, 侯晓玮, 等. 影像引导下经皮微波局部消融治疗原发性肝癌疗效观察[J]. 中华消化病与影像杂志, 2013, 3(3): 32-34.
[6] 曾鹏, 周乐杜, 王栋, 等. 射频消融治疗小肝癌疗效及预后因素分析[J]. 中国普通外科杂志, 2014, 23(7): 904-909. ZENG Peng, ZHOU Ledu, WANG Dong, et al. Radiofrequency ablation for small hepatocellular carcinoma: efficacy and prognostic factors[J]. Chinese Journal of General Surgery, 2014, 23(7): 904-909.
[7] 许贇, 王能, 沈强, 等. 经皮热消融治疗极早期肝癌的疗效及预后因素分析[J].中国普通外科杂志, 2015, 24(7): 945-951. XU Yun, WANG Neng, SHEN Qiang, et al. Percutaneous thermal ablation for very early stage hepatocellular carcinoma: efficacy and prognostic factors[J]. Chinese Journal of General Surgery, 2015, 24(7): 945-951.
[8] Hoffmann R, Rempp H, Erhard L, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver[J]. Radiology, 2013, 268(1): 89-97.
[9] Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. J Gastroen Hepatol, 2014, 29(1): 193-200.
[10] Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroen Hepatol, 2014, 29(7): 1500-1507.
[11] Medhat E, Abdel Aziz A, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma[J]. J Dig Dis, 2015, 16(8): 345-463.
[12] 庄兴俊, 王宁宁, 侯晓玮, 等. 人工气胸后氩氦刀冷冻治疗近膈顶部肝癌4例[J]. 中华肝脏病杂志, 2012, 20(6): 479.
[13] Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study[J]. Radiology, 2012, 262(3): 1022-1033.
[14] Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma[J]. Ann Surg Oncol, 2004, 11(12): 1061-1069.
[15] Gómez Portilla A1, Cendoya I, Olabarría I, et al. The European contribution to “Sugarbakers protocol” for the treatment of colorectal peritoneal carcinomatosis[J]. Rev Esp Enferm Dig, 2009, 101(2): 97-102, 103-106.
[16] Pathak S, Jones R, Tang JM, et al. Ablative therapies for colorectal liver metastases: a systematic review[J]. Colorectal Dis, 2011, 13(9): e252-265.
[1] JIANG Shu1, JIANG Zhaofu2, WANG Xinyi1, YANG Zhiqiang1, ZHANG Jingjian1. A preliminary study on the characterization of benign or malignant portal vein thrombosis with spectral CT [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 81-84.
[2] KONG Xiang-gen1, HAN Shao-lei2, ZHENG Zhao-min2, DU Wen-jun2, CHEN Shi-jun2. Values of Golgi protein 73 and Alpha-fetoprotein-L3 in the  diagnosis of primary hepatic carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 110-114.
[3] LI Cai-xia,LI Chun-hai. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(12): 1284-1287.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd